'We Expect A Quick Resolution': Despite Partial Clinical Hold On Epizyme's Drug Candidate, Wedbush Stays Bullish

Epizyme Inc (NASDAQ: EPZM)'s announcement that the FDA was placing a partial hold on its lead cancer candidate tazemetostat has ...